当前位置: X-MOL 学术JAMA Neurol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Barriers to Tofersen Therapy for Variant SOD1-Mediated ALS
JAMA Neurology ( IF 20.4 ) Pub Date : 2024-10-07 , DOI: 10.1001/jamaneurol.2024.3331
Stanley H. Appel, Jason R. Thonhoff

This Viewpoint advocates for the accelerated adoption of tofersen therapy to treat patients with variant SOD1-mediated amyotrophic lateral sclerosis (ALS) and describes the current barriers to treatment.

中文翻译:


Tofersen 疗法治疗变异型 SOD1 介导的 ALS 的障碍



该观点倡导加速采用 tofersen 疗法来治疗变异型 SOD1 介导的肌萎缩侧索硬化症 (ALS) 患者,并描述了目前的治疗障碍。
更新日期:2024-10-07
down
wechat
bug